Phase II Study of Lucanix (TGF-beta2 Antisense Gene Modified Allogeneic Tumor Cell Vaccine) in Patients With Stages II-IV Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2015
At a glance
- Drugs Belagenpumatucel-L (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 27 Sep 2011 Results presented at the 2011 European Multidisciplinary Cancer Congress.
- 06 Feb 2010 New trial record